Why the study?
What are the early and midterm outcomes of Bentall procedures using the all-biological valved BioConduit™?
What are the early and midterm outcomes of Bentall procedures using the all-biological valved BioConduit™?
The use of the all-biological valved BioConduit™ in Bentall procedures is associated with an unexpectedly high rate of early and midterm non-structural prosthetic hemodynamic deterioration.
Answers are grounded in this paper and cite their sources.
May warrant closer surveillance for BioConduit™ deterioration; leaves open durability questions pending prospective trials.
We are reporting early and midterm results of Bentall procedures with the all-biological, valved, No-React® BioConduit™. To our knowledge, this is the first study reporting an early and midterm unexpectedly high rate of non-structural prosthetic hemodynamic deterioration. The rate of endocarditis and atrioventricular disconnections remain similar to previous studies.
No takes yet. Share an insight, caveat, or question.
Botea et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: